Interferon-free antiviral therapy does not increase the risk of developing short term hepatocellular carcinoma in patients with cirrhosis infected with hepatitis C virus

被引：1
|
作者：
Nunez, A. [1 ]
Aguilera, V. [1 ]
Sanchez-Torrijos, Y. [1 ]
Sousa, J. M. [1 ,2 ]
Ferrer, M. T. [1 ,2 ]
Giraldez, A. [1 ,2 ]
Ampuero, J. [3 ,4 ]
Perez-Martinez, J. [1 ]
Cuaresma, M. [2 ,5 ]
Ruiz-Perez, R. [2 ,5 ]
Pascasio, J. M. [3 ,4 ]
机构：
[1] Hosp Univ Virgen del Rocio, Digest Dis, Seville, Spain
[2] Hosp Univ Virgen del Rocio, IBIS, Seville, Spain
[3] Hosp Univ Virgen del Rocio, IBIS, Digest Dis, Seville, Spain
[4] Hosp Univ Virgen del Rocio, CIBERehd, Seville, Spain
[5] Hosp Univ Virgen del Rocio, FISEVI, Seville, Spain
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(17)31325-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-131
引用
收藏
页码：S469 / S469
页数：1
相关论文
共 50 条
  • [31] Hepatitis C virus antiviral therapy in patients with cirrhosis
    Arenas, JI
    Vargas, HE
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2004, 33 (03) : 549 - +
  • [32] Role of ribavirin in interferon-free therapy for the treatment of hepatitis C virus
    Maria Morillas, Rosa
    Masnou, Helena
    Ardevol, Merce
    Lopez, Dulce
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2017, 40 (10): : 699 - 708
  • [33] TLL1 variant associated with development of hepatocellular carcinoma after eradication of hepatitis C virus by interferon-free therapy
    Etsuko Iio
    Kentaro Matsuura
    Noritomo Shimada
    Masanori Atsukawa
    Norio Itokawa
    Hiroshi Abe
    Keizo Kato
    Koichi Takaguchi
    Tomonori Senoh
    Yuichiro Eguchi
    Hideyuki Nomura
    Kai Yoshizawa
    Jong-Hon Kang
    Takeshi Matsui
    Noboru Hirashima
    Atsunori Kusakabe
    Tomokatsu Miyaki
    Kei Fujiwara
    Kayoko Matsunami
    Susumu Tsutsumi
    Katsuhiko Iwakiri
    Yasuhito Tanaka
    Journal of Gastroenterology, 2019, 54 : 339 - 346
  • [34] The Socio-Economic Burden of Untreated Hepatitis C Virus Infected Patients in the Era of New Interferon-Free Therapy
    Cuciureanu, Tudor
    Trifan, Anca
    Stanciu, Carol
    Chiriac, Stefan
    Sfarti, Catalin
    Muzica, Cristina Maria
    Singeap, Ana Maria
    Miftode, Larisa
    Huiban, Laura
    REVISTA DE CERCETARE SI INTERVENTIE SOCIALA, 2018, 60 : 65 - 78
  • [35] TLL1 variant associated with development of hepatocellular carcinoma after eradication of hepatitis C virus by interferon-free therapy
    Iio, Etsuko
    Matsuura, Kentaro
    Shimada, Noritomo
    Atsukawa, Masanori
    Itokawa, Norio
    Abe, Hiroshi
    Kato, Keizo
    Takaguchi, Koichi
    Senoh, Tomonori
    Eguchi, Yuichiro
    Nomura, Hideyuki
    Yoshizawa, Kai
    Kang, Jong-Hon
    Matsui, Takeshi
    Hirashima, Noboru
    Kusakabe, Atsunori
    Miyaki, Tomokatsu
    Fujiwara, Kei
    Matsunami, Kayoko
    Tsutsumi, Susumu
    Iwakiri, Katsuhiko
    Tanaka, Yasuhito
    JOURNAL OF GASTROENTEROLOGY, 2019, 54 (04) : 339 - 346
  • [36] Long-term evaluation of interferon therapy in hepatitis C virus-associated cirrhosis: Does IFN prevent development of hepatocellular carcinoma?
    Tanaka, K
    Sata, M
    Uchimura, Y
    Suzuki, H
    Tanikawa, K
    ONCOLOGY REPORTS, 1998, 5 (01) : 205 - 208
  • [37] Risk of recurrence of hepatocellular carcinoma in patients treated with interferon-free antivirals
    Hernaez-Alsina, Tania
    Caballol-Oliva, Berta
    Diaz-Gonzalez, Alvaro
    Guedes-Leal, Cassia
    Reig, Maria
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2019, 42 (08): : 502 - 511
  • [38] Risk of hepatocellular carcinoma in patients with chronic hepatitis C who achieve sustained virologic response with interferon-free versus interferon-based therapy in Japan
    Miyase, Shiho
    Kugiyama, Aya
    Tsukano, Natsumi
    Iwashita, Hirofumi
    Fujiyama, Shigetoshi
    HEPATOLOGY, 2017, 66 : 742A - 742A
  • [39] Risk of hepatocellular carcinoma among patients with hepatitis C virus cirrhosis treated with direct-acting antiviral therapy: An Australian experience
    Snell, J.
    Hong, T.
    Glasgow, S.
    Papaluca, T.
    New, K.
    Mcclure, T.
    Bell, S.
    Demeduik, B.
    Jeremiah, C.
    Tran, S.
    Phan, D.
    Jarman, M.
    Iser, D.
    Lust, M.
    Shaw, G.
    Desmond, P.
    Croagh, C.
    Visvanathan, K.
    Howell, J.
    Ryan, M.
    Thompson, A. J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 80 - 81
  • [40] Does past infection with hepatitis B increase the risk of hepatocellular carcinoma in hepatitis C induced cirrhosis?
    Natr, S
    Perrillo, RP
    GASTROENTEROLOGY, 2003, 124 (04) : A774 - A774
12345